InvestSMART

ECS Botanics Holdings Ltd (ASX: ECS) - Share Price

- Current share price for ECS : $0.005

ECS Botanics Holdings Ltd (ECS), an ASX-listed company, is an Australian medicinal cannabis cultivator and manufacturer based in Northwest Victoria.

ECS General Information +

ASX Code ECS
Website N/A
Industry/Sector Pharmaceuticals
Market Cap ($M) 8
ECS Share Price $0.005
Day High $0.000
Day Low $0.000
Last Close $0.005
ECS Share Price Movement - ( No change )
Prices as at 16:40, 9 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

ECS Botanics Holdings Ltd (ECS) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from ECS Botanics Holdings Ltd (ECS) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

ECS Botanics Holdings Ltd (ECS) price-sensitive announcements

ECS - German GMP Update Reinforces ECS Manufacturing Strategy
ECS Botanics Holdings Ltd, a prominent medicinal cannabis company, announced that new GMP
ECS Botanics Holdings Ltd (ECS)
3 Jul 2026 | 9:34 AM
ECS - ECS Launches First Australian-Grown Terphogz Product
ECS Botanics Holdings Ltd has launched Gelonoidz #20, the first Australian-grown Terphogz
ECS Botanics Holdings Ltd (ECS)
22 Jun 2026 | 8:16 AM
ECS - Quarterly Activities/Appendix 4C Cash Flow Report
ECS Botanics Holdings Ltd reported its third consecutive positive cash flow quarter, with
ECS Botanics Holdings Ltd (ECS)
28 Apr 2026 | 8:14 AM
ECS - H1 FY26 Results-Return to Profitability & Positive Cashflow
ECS Botanics Holdings Ltd reported a significant turnaround in its financial performance f
ECS Botanics Holdings Ltd (ECS)
27 Feb 2026 | 12:02 PM

ECS Botanics Holdings Ltd (ECS) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 German GMP Update Reinforces ECS Manufacturing Strategy 3 Jul 2026 9:34AM $0.003 $0.005 risen by 66.67%
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 Cleansing Statement 1 Jul 2026 1:24PM $0.004 $0.005 risen by 25%
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 Application for quotation of securities - ECS 1 Jul 2026 1:23PM $0.004 $0.005 risen by 25%
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 Change of Director's Interest Notice 1 Jul 2026 11:13AM $0.004 $0.005 risen by 25%
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 Notification of cessation of securities - ECS 1 Jul 2026 11:11AM $0.004 $0.005 risen by 25%
ECS Botanics Holdings Ltd (ECS)
ORDINARY FULLY PAID
Health Care $8 ECS Launches First Australian-Grown Terphogz Product 22 Jun 2026 8:16AM $0.005 $0.005 risen by 11.11%

ECS Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$2.79 -$0.20 -237.50% 0.00 0.00 0.00% 0.0%
2024A $1.99 $0.20 300.00% 13.90 0.00 0.00% 0.0%
2023A $0.49 N2 -136.40% 56.50 0.00 0.00% 0.0%

ECS Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Clarity Pharmaceuticals Ltd (CU6) $892M 0.3002 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
ECS Botanics Holdings Ltd (ECS) $8M -2.3750 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Neuren Pharmaceuticals Limited (NEU) $2,071M -0.7857 0.0743 1.2000 70.2192 65.3600 29.7091 0.00% 0.00% 0.00%

ECS Directors

Name Position Start Date
Ms Nan-Maree Schoerie Managing Director 15 Mar 2021
Mr Michael Nitsche Non-Executive Director 25 Mar 2019
Mr Jeremy Philip King Non-Executive Director, Non-Executive Chairman 11 Jan 2017

ECS Botanics Holdings Ltd (ECS) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
29 Jan 2026 SCHOERIE, Nan-Maree Issued Options 20,194,443 $0.009 $181,166.658
29 Jan 2026 KING, Jeremy Issued Options 1,016,413 $0.006 $6,098.478
20 Jun 2025 SCHOERIE, Nan-Maree Buy Indirect Shares 1,000,000 $0.009 $9,000.000

See all changes in directors' interest & trades for ECS Botanics Holdings Ltd (ECS) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ECS Management

Name Position
Xiao Dong (Arthur) Sun Chief Financial Officer
Nicholas Thomas Chief Operating Officer
Mauro Piccini Company Secretary

ECS Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in ECS Botanics Holdings Ltd (ECS). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
67,000,000 (5.17%) Schoerie Fides Pty Ltd

ECS Calendar of Events

Date Event
03 March 2027 Report (Interim)
26 February 2027 Report (Interim)
28 August 2026 Report (Annual)
28 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.